Inato

Inato (operating at inato.com) is a platform that connects global pharmaceutical companies with a broader range of research sites, while ensuring reliable high performance. Founded in 2016 and headquartered in Paris, Inato empowers community-based research sites worldwide to review trials from leading pharmaceutical companies and select the ones best-fit for their patients. Under the hood, Inato combines trial planning, site selection, and patient pre-screening into a single AI-enabled platform to make research more accessible and efficient. This allows community-based investigators to bring the right trials to their patients, regardless of who they are. Backed by Cathay Innovation and Obvious Ventures.